
Biographie pas encore disponible.
Actualités

Publication
01
Mar
2024
Publication IPMC / Brain, Behavior, and Immunity / Équipe Barrès
La composition en acides gras de l’alimentation est à l’origine de la neuroinflammation et de l’altération du comportement dans l’obésité […]

Publication
13
Nov
2025
Publication IPMC/J Cereb Blood Flow Metab./ Dr. Nicolas Blondeau/Equipe G. Lambeau
In close collaboration with the team of M. Tauc and D. Pisani (Université Côte d’Azur, CNRS, LP2M), our study identifies […]
Publications
2025
How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind?,
Life, 2025, 15 (6), pp.883. ⟨10.3390/life15060883⟩.
2025
Deciphering the brain glucose metabolism: A gateway to innovative stroke therapies,
Journal of Cerebral Blood Flow and Metabolism, In press, ⟨10.1177/0271678x251346277⟩.
2025
Targeting seryl-tRNA synthetase to unlock ischemic resilience in stroke – Insights from a proof-of-concept study,
Journal of Cerebral Blood Flow and Metabolism, 2025, ⟨10.1177/0271678x251347810⟩.
2024
Alpha-Linolenic Acid: a pleiotropic option for protecting the brain from Ischemic stroke and managing metabolic comorbidities,
The International Symposium on Neuroprotection and Neurorepair (ISN&N), Nov 2024, Potsdam, Germany.
2024
Optimization of Cell Penetrating Poly-Arginine Peptides to Provide a Superior Therapeutic Index Against Severe Excitotoxic Insults In Vitro,
11th International Symposium on Neuroprotection an Neurorepair 2024, Nov 2024, Potsdam, Germany.
2024
Dietary fatty acid composition drives neuroinflammation and impaired behavior in obesity,
Brain, Behavior, and Immunity, 2024, 117, pp.330-346. ⟨10.1016/j.bbi.2024.01.216⟩.
2024
Enhancing Solubility and Bioefficacy of Stilbenes by Liposomal Encapsulation─The Case of Macasiamenene F,
ACS Omega, 2024, ⟨10.1021/acsomega.3c07380⟩.
2023
Unlocking Therapeutic Synergy: Tailoring Drugs for Comorbidities such as Depression and Diabetes through Identical Molecular Targets in Different Cell Types,
Cells, 2023, 12 (23), pp.2768. ⟨10.3390/cells12232768⟩.
2022
Linotrins: Omega-3 oxylipins featuring an E,Z,E conjugated triene motif are present in the plant kingdom and alleviate inflammation in LPS-challenged microglial cells,
European Journal of Medicinal Chemistry, 2022, 231, pp.114157. ⟨10.1016/j.ejmech.2022.114157⟩.
2021
The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles,
Cell & Bioscience, 2021, 11 (1), ⟨10.1186/s13578-021-00733-y⟩.
2021
Targeting oxidative stress, a crucial challenge in renal transplantation outcome,
Free Radical Biology and Medicine, 2021, 169, pp.258-270. ⟨10.1016/j.freeradbiomed.2021.04.023⟩.
2021
Combattre l’accident vasculaire cérébral en inhibant une enzyme liée à la voie de synthèse des polyamines,
Médecine/Sciences, 2021, 37 (6-7), pp.575-577. ⟨10.1051/medsci/2021068⟩.
2021
Inhibition of eIF5A hypusination reprogrammes metabolism and glucose handling in mouse kidney,
Cell Death and Disease, 2021, 12 (4), ⟨10.1038/s41419-021-03577-z⟩.
2021
Dietary fat exacerbates postprandial hypothalamic inflammation involving glial fibrillary acidic protein-positive cells and microglia in male mice,
Glia, 2021, 69 (1), pp.42-60. ⟨10.1002/glia.23882⟩.
2021
Sortilin-derived peptides promote pancreatic beta-cell survival through CREB signaling pathway,
Pharmacological Research, 2021, 167, pp.105539. ⟨10.1016/j.phrs.2021.105539⟩.
2020
Therapeutic potential of prenylated stilbenoid macasiamenene F through its anti-inflammatory and cytoprotective effects on LPS-challenged monocytes and microglia,
Journal of Ethnopharmacology, 2020, pp.113147. ⟨10.1016/j.jep.2020.113147⟩.
2020
Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy,
Journal of Cerebral Blood Flow and Metabolism, 2020, pp.0271678X2092888. ⟨10.1177/0271678X20928882⟩.
2019
An acute coronary syndrome in Antarctica,
International maritime health, 2019, 70 (3), pp.167-170. ⟨10.5603/IMH.2019.0026⟩.
2019
Bridging the Gap Between Diabetes and Stroke in Search of High Clinical Relevance Therapeutic Targets,
NeuroMolecular Medicine, 2019, ⟨10.1007/s12017-019-08563-5⟩.
2019
A new pharmacological preconditioning-based target: from drosophila to kidney transplantation,
Conditioning Medicine, 2019.
2019
Sortilin in Glucose Homeostasis: From Accessory Protein to Key Player?,
Frontiers in Pharmacology, 2019, 9, ⟨10.3389/fphar.2018.01561⟩.
2018
Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets,
Frontiers in Neuroscience, 2018, 12, ⟨10.3389/fnins.2018.00510⟩.
2018
Cruise ship pathologies in remote regions,
International maritime health, 2018, 69 (2), pp.75-83. ⟨10.5603/IMH.2018.0012⟩.
2018
Requirement for preclinical prioritization of neuroprotective strategies in stroke: Incorporation of preconditioning,
Conditioning Medicine, 2018.
2017
Hypothalamic Inflammation and Energy Balance Disruptions: Spotlight on Chemokines,
Frontiers in Endocrinology, 2017, 8, ⟨10.3389/fendo.2017.00197⟩.
2017
Tackling issues in the path toward clinical translation in brain conditioning: Potential offered by nutraceuticals,
Brain Circulation, 2017, ⟨10.4103/bc.bc_8_17⟩.
2017
Targeting eIF5A Hypusination Prevents Anoxic Cell Death through Mitochondrial Silencing and Improves Kidney Transplant Outcome,
Journal of the American Society of Nephrology, 2017, 28 (3), pp.811-822. ⟨10.1681/ASN.2016010012⟩.
2016
Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation,
EMBO Reports, 2016, 17 (12), pp.1738-1752. ⟨10.15252/embr.201541499⟩.
2016
Alpha-linolenic acid given as enteral or parenteral nutritional intervention against sensorimotor and cognitive deficits in a mouse model of ischemic stroke,
Neuropharmacology, 2016, 108, pp.60-72. ⟨10.1016/j.neuropharm.2016.04.040⟩.
2016
Failure and rescue of preconditioning-induced neuroprotection in severe stroke-like insults,
Neuropharmacology, 2016, 105, pp.533-542. ⟨10.1016/j.neuropharm.2016.02.007⟩.
2016
A Potent Protective Role of Lysophospholipids Against Global Cerebral Ischemia and Glutamate Excitotoxicity in Neuronal Cultures,
Journal of Cerebral Blood Flow and Metabolism, 2016, 22 (7), pp.821-834. ⟨10.1097/00004647-200207000-00007⟩.
2016
The nutraceutical potential of omega-3 alpha-linolenic acid in reducing the consequences of stroke,
Biochimie, 2016, 120, pp.49-55. ⟨10.1016/j.biochi.2015.06.005⟩.
2015
The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects,
Annals of the New York Academy of Sciences, 2015, 1351 (1), pp.127-140. ⟨10.1111/nyas.12855⟩.
2015
Alpha-Linolenic Acid: An Omega-3 Fatty Acid with Neuroprotective Properties—Ready for Use in the Stroke Clinic?,
BioMed Research International , 2015, 2015, pp.1-8. ⟨10.1155/2015/519830⟩.
2014
Oxygen glucose deprivation-induced astrocyte dysfunction provokes neuronal death through oxidative stress,
Pharmacological Research, 2014, 87, pp.8-17. ⟨10.1016/j.phrs.2014.06.002⟩.
2013
Alpha-linolenic acid: A promising nutraceutical for the prevention of stroke,
PharmaNutrition, 2013, 1 (1), pp.1-8.
2013
Alpha-linolenic acid: A promising nutraceutical for the prevention of stroke,
PharmaNutrition, 2013, 1 (1), pp.1-8. ⟨10.1016/j.phanu.2012.12.002⟩.
2011
Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis.,
Journal of Biological Chemistry, 2011, 286 (33), pp.28858-66. ⟨10.1074/jbc.M111.273292⟩.
2011
Alpha-linolenic omega-3 fatty acid for stroke protection: from brain preconditioning paradigm to nutrition,
Oléagineux, Corps Gras, Lipides, 2011, ⟨10.1684/ocl.2011.0389⟩.
2010
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.,
Journal of Neuroimmunology, 2010, 224 (1-2), pp.93-100. ⟨10.1016/j.jneuroim.2010.05.010⟩.
2010
Association of phenylbutazone usage with horses bought for slaughter: a public health risk.,
Food and Chemical Toxicology, 2010, 48 (5), pp.1270-4. ⟨10.1016/j.fct.2010.02.021⟩.
2010
Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke.,
Pharmacological Research, 2010, 61 (3), pp.226-33. ⟨10.1016/j.phrs.2009.12.007⟩.
2009
Subchronic Alpha-Linolenic Acid Treatment Enhances Brain Plasticity and Exerts an Antidepressant Effect: A Versatile Potential Therapy for Stroke.,
Neuropsychopharmacology, 2009, epub ahead of print. ⟨10.1038/npp.2009.84⟩.
2008
Brain adaptation to stressful stimuli: a new perspective on potential therapeutic approaches based on BDNF and NMDA receptors.,
CNS Neurol Disord Drug Targets, 2008, 7 (4), pp.382-90.
2008
Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis.,
Neurochemical Research, 2008, 33 (9), pp.1859-68. ⟨10.1007/s11064-008-9658-0⟩.
2007
Distribution of sphingosine kinase activity and mRNA in rodent brain,
Journal of Neurochemistry, 2007, 103 (2), pp.509-517. ⟨10.1111/j.1471-4159.2007.04755.x⟩.
2007
Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel.,
Circulation Research, 2007, 101 (2), pp.176-84. ⟨10.1161/CIRCRESAHA.107.154443⟩.
2007
A tarantula peptide against pain via ASIC1a channels and opioid mechanisms.,
Nature Neuroscience, 2007, 10 (8), pp.943-945. ⟨10.1038/nn1940⟩.
2007
Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli,
Amino Acids, 2007, 32 (3), pp.299-304. ⟨10.1007/s00726-006-0414-y⟩.
2007
Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link.,
EMBO Reports, 2007, 8 (4), pp.354-9. ⟨10.1038/sj.embor.7400916⟩.
2006
TREK-1, a K+ channel involved in polymodal pain perception.,
EMBO J 2006 Jun; 25(11): 2368-76.
2006
TREK-1, a K+ channel involved in polymodal pain perception.,
EMBO Journal, 2006, 25, pp.2368-2376.
2006
Les acides gras essentiels de la famille des oméga-3 et la santé de la mère et de l’enfant
Omega-3 fatty acids for mother and child health,
Nutrition Clinique et Métabolisme, 2006, 20 (2), pp.68-72. ⟨10.1016/j.nupar.2006.04.008⟩.
2006
Alpha-Linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia,
Neuroscience, 2006, 137, pp.241-251.
2006
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype,
Nature Neuroscience, 2006, 9, pp.1134-1141. ⟨10.1038/nn1749⟩.
2005
Le role majeur du canal potassique TREK-1 dans la protection neuronale induite par les omega-3,
OCL, 2005, xx, pp.77.
2004
[Cerebral tolerance: a promising choice towards new treatments for neurologic diseases].,
Med Sci (Paris) 2004 Dec; 20(12): 1109-14.
2004
TREK-1, a K+ channel involved in neuroprotection and general anesthesia,
EMBO Journal, 2004, 23 (13), pp.2684-2695. ⟨10.1038/sj.emboj.7600234⟩.
2004
TREK-1, a K+ channel involved in neuroprotection and general anaesthesia,
EMBO Journal, 2004, 23, pp.2684-2695.
2004
Vascular sphingosine-1-phosphate S1P(1) and S1P(3) receptors,
Drug News perspect., 2004, xx, pp.382.
2004
Cerebral Tolerance: a new challenge to identify targets for cerebral protection,
Médecine/Sciences, 2004, 20, pp.1109-1114.
2003
Linolenic acid prevents neuronal cell death and paraplegia following transient spinal cord ischemia in rats,
Journal of Vascular Surgery, 2003, 38, pp.564-575.
2002
Polyunsaturated fatty acids induce ischemic and epileptic tolerance,
Neuroscience, 2002, 109, pp.231-241.
2002
A potent protective role of lysophospholipids against global cerebral ischemia and glutamate-excitotoxicity in neuronal cultures,
Journal of Cerebral Blood Flow and Metabolism, 2002, 22, pp.821-834.
2002
POLYUNSATURATED FATTY ACIDS INDUCE ISCHEMIC AND EPILEPTIC TOLERANCE,
Neuroscience, 2002, 109 (2), pp.231-241. ⟨10.1016/s0306-4522(01)00473-0⟩.
2001
Activation of the Nuclear Factor-κB Is a Key Event in Brain Tolerance,
Journal of Neuroscience, 2001, 21 (13), pp.4668-4677. ⟨10.1523/JNEUROSCI.21-13-04668.2001⟩.
2001
ATP-sensitive potassium channels (K ) in retina: a key role for ATP delayed ischemic tolerance,
Brain Research, 2001, 890 (1), pp.118 - 129. ⟨10.1016/s0006-8993(00)03152-8⟩.
2000
Polyunsaturated fatty acids are potent neuroprotectors,
EMBO Journal, 2000, 19 (8), pp.1784-1793. ⟨10.1093/emboj/19.8.1784⟩.
2000
K ATP CHANNEL OPENERS, ADENOSINE AGONISTS AND EPILEPTIC PRECONDITIONING ARE STRESS SIGNALS INDUCING HIPPOCAMPAL NEUROPROTECTION,
Neuroscience, 2000, 100 (3), pp.465-474. ⟨10.1016/S0306-4522(00)00304-3⟩.
1999
Mutually Protective Actions of Kainic Acid Epileptic Preconditioning and Sublethal Global Ischemia on Hippocampal Neuronal Death: Involvement of Adenosine A 1 Receptors and K ATP Channels,
Journal of Cerebral Blood Flow and Metabolism, 1999, 19 (12), pp.1296-1308. ⟨10.1097/00004647-199912000-00002⟩.

